Published in Anal Chim Acta on March 17, 2009
High-sensitivity electrochemical enzyme-linked assay on a microfluidic interdigitated microelectrode. Biosens Bioelectron (2011) 0.79
A Modular, DNA-Based Beacon for Single-Step Fluorescence Detection of Antibodies and Other Proteins. Angew Chem Int Ed Engl (2015) 0.77
On-chip Extraction of Intracellular Molecules in White Blood Cells from Whole Blood. Sci Rep (2015) 0.75
Protein quality in bacterial inclusion bodies. Trends Biotechnol (2006) 2.02
Amyloid-like properties of bacterial inclusion bodies. J Mol Biol (2005) 1.90
Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact (2008) 1.89
Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact (2005) 1.79
Microbial factories for recombinant pharmaceuticals. Microb Cell Fact (2009) 1.59
The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol Bioeng (2007) 1.34
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res (2002) 1.23
Recombinant protein solubility - does more mean better? Nat Biotechnol (2007) 1.21
Localization of functional polypeptides in bacterial inclusion bodies. Appl Environ Microbiol (2006) 1.20
Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J Mol Biol (2007) 1.18
Role of molecular chaperones in inclusion body formation. FEBS Lett (2003) 1.16
Localization of chaperones DnaK and GroEL in bacterial inclusion bodies. J Bacteriol (2005) 1.12
Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact (2009) 1.09
Nanotechnology, bionanotechnology and microbial cell factories. Microb Cell Fact (2010) 1.09
Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol (2009) 1.08
Bacterial inclusion bodies: making gold from waste. Trends Biotechnol (2011) 1.07
Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol Adv (2012) 1.05
Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact (2010) 1.05
Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J (2011) 1.01
Folding of a misfolding-prone beta-galactosidase in absence of DnaK. Biotechnol Bioeng (2005) 1.01
Side effects of chaperone gene co-expression in recombinant protein production. Microb Cell Fact (2010) 1.01
Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology (2010) 1.00
Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli. Biotechnol Bioeng (2008) 0.99
Nanostructured bacterial materials for innovative medicines. Trends Microbiol (2010) 0.95
Engineering building blocks for self-assembling protein nanoparticles. Microb Cell Fact (2010) 0.95
The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells. Microb Cell Fact (2006) 0.95
The Functional quality of soluble recombinant polypeptides produced in Escherichia coli is defined by a wide conformational spectrum. Appl Environ Microbiol (2008) 0.94
Detection of Escherichia coli and Salmonella typhimurium using interdigitated microelectrode capacitive immunosensors: the importance of transducer geometry. Anal Chem (2008) 0.93
Membrane-active peptides for non-viral gene therapy: making the safest easier. Trends Biotechnol (2008) 0.91
The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials (2010) 0.90
Systems metabolic engineering, industrial biotechnology and microbial cell factories. Microb Cell Fact (2012) 0.90
Toward membrane-free amperometric gas sensors: a microelectrode array approach. Anal Chem (2010) 0.89
Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury. Brain Pathol (2011) 0.89
Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv Mater (2012) 0.89
Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes. Biochem Pharmacol (2002) 0.88
Modular protein engineering for non-viral gene therapy. Trends Biotechnol (2004) 0.88
Bacterial inclusion bodies are cytotoxic in vivo in absence of functional chaperones DnaK or GroEL. J Biotechnol (2005) 0.87
Insertional protein engineering for analytical molecular sensing. Microb Cell Fact (2006) 0.87
Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptide. Nanomedicine (Lond) (2010) 0.87
Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies. Biochem Biophys Res Commun (2007) 0.87
Modular protein engineering in emerging cancer therapies. Curr Pharm Des (2009) 0.86
Role of the chaperone DnaK in protein solubility and conformational quality in inclusion body-forming Escherichia coli cells. FEMS Microbiol Lett (2007) 0.86
Peptide-mediated DNA condensation for non-viral gene therapy. Biotechnol Adv (2009) 0.86
A new bisintercalating anthracycline with picomolar DNA binding affinity. J Med Chem (2005) 0.86
Influence of growth temperature on the production of antibody Fab fragments in different microbes: a host comparative analysis. Biotechnol Prog (2010) 0.86
On-chip electric field driven electrochemical detection using a poly(dimethylsiloxane) microchannel with gold microband electrodes. Anal Chem (2008) 0.85
Production of functional inclusion bodies in endotoxin-free Escherichia coli. Appl Microbiol Biotechnol (2014) 0.85
Profiling the allosteric response of an engineered beta-galactosidase to its effector, anti-HIV antibody. Biochem Biophys Res Commun (2004) 0.85
Rehosting of bacterial chaperones for high-quality protein production. Appl Environ Microbiol (2009) 0.84
Bacterial cell factories for recombinant protein production; expanding the catalogue. Microb Cell Fact (2013) 0.84
Post-production protein stability: trouble beyond the cell factory. Microb Cell Fact (2011) 0.84
Transient storage of electrical charge in biofilms of Shewanella oneidensis MR-1 growing in a microbial fuel cell. Environ Sci Technol (2011) 0.84
Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine. Microb Cell Fact (2011) 0.83
Internalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticles. Biomaterials (2010) 0.83
In situ protein folding and activation in bacterial inclusion bodies. Biotechnol Bioeng (2008) 0.83
Self-assembled monolayers as a base for immunofunctionalisation: unequal performance for protein and bacteria detection. Anal Bioanal Chem (2008) 0.83
Lon and ClpP proteases participate in the physiological disintegration of bacterial inclusion bodies. J Biotechnol (2005) 0.83
Regular arrays of microdisc electrodes: simulation quantifies the fraction of 'dead' electrodes. Analyst (2005) 0.82
Integrating mechanical and biological control of cell proliferation through bioinspired multieffector materials. Nanomedicine (Lond) (2015) 0.82
Recombinant protein quality evaluation: proposal for a minimal information standard. Stand Genomic Sci (2011) 0.82
Magnetic entrapment for fast, simple and reversible electrode modification with carbon nanotubes: application to dopamine detection. Biosens Bioelectron (2010) 0.81
Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A. Appl Microbiol Biotechnol (2015) 0.81
Peptide-assisted traffic engineering for nonviral gene therapy. Drug Discov Today (2008) 0.81
Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochem Biophys Res Commun (2003) 0.81
A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631. Eur J Biochem (2003) 0.81
Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles. Int J Nanomedicine (2012) 0.81
A new method for the study of processes at the liquid-liquid interface using an array of microdroplets on a au electrode. Chemphyschem (2006) 0.81
Diffusional protection of electrode surfaces using regular arrays of immobilised droplets: overcoming interferences in electroanalysis. Analyst (2006) 0.81
Gold immuno-functionalisation via self-assembled monolayers: study of critical parameters and comparative performance for protein and bacteria detection. J Immunol Methods (2008) 0.81
Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors. Biochim Biophys Acta (2002) 0.81
DnaK/DnaJ-assisted recombinant protein production in Trichoplusia ni larvae. Appl Microbiol Biotechnol (2009) 0.80
Gold ultra-microelectrode arrays: application to the steady-state voltammetry of hydroxide ion in aqueous solution. Anal Sci (2006) 0.80
Interleukin-10 overexpression does not synergize with the neuroprotective action of RGD-containing vectors after postnatal brain excitotoxicity but modulates the main inflammatory cell responses. J Neurosci Res (2011) 0.80
The impact of dnaKJ overexpression on recombinant protein solubility results from antagonistic effects on the control of protein quality. Biotechnol Lett (2004) 0.80
Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies. Acta Biomater (2012) 0.80
Enzyme shadowing: using antibody-enzyme dually-labeled magnetic particles for fast bacterial detection. Analyst (2008) 0.79
Immunofunctionalisation of gold transducers for bacterial detection by physisorption. Anal Bioanal Chem (2008) 0.79
Sensing bacteria but treating them well: determination of optimal incubation and storage conditions. Anal Biochem (2008) 0.79
Microbial biofabrication for nanomedicine: biomaterials, nanoparticles and beyond. Nanomedicine (Lond) (2013) 0.79
A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs. Nanomedicine (Lond) (2013) 0.79
Biosensing at disk microelectrode arrays. Inter-electrode functionalisation allows formatting into miniaturised sensing platforms of enhanced sensitivity. Biosens Bioelectron (2009) 0.79
Bioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineering. Nanomedicine (Lond) (2011) 0.79
Cellular uptake and intracellular fate of protein releasing bacterial amyloids in mammalian cells. Soft Matter (2016) 0.79
Analytical approaches for assessing aggregation of protein biopharmaceuticals. Curr Pharm Biotechnol (2011) 0.79